News & Events

Go

News RSS Feed

Smith Medical Partners Obtains Agreement to Distribute Leading Oncology Drugs from Endo Pharmaceuticals

Smith Medical Partners is pleased to announce an agreement with Endo Pharmaceuticals to distribute VANTASĀ® (histrelin implant), VALSTARĀ® (valrubicin) and SUPPRELINĀ® LA (histrelin acetate) subcutaneous implant.

Smith Medical Partners to Distribute Significant Plasma Products

The following Grifols plasma derivatives are now available through Smith Medical Partners: Alphanate, Alphanine and Profilnine.

See all »

Save money. Save lives.

Dose Calculator

Registration is free and only takes a few minutes.

Find out more

Success Story

ASAP Pharmacy turned to SMP because of its reputation for service.

Read the story

Infosnack:

15%

of drug spending in the United States is from specialty pharmaceuticals.